| Type | Title | Date Released | |
|---|---|---|---|
SCHEDULE 13G | Venrock Healthcare Capital Partners III, L.P. (Filed by) | ||
8-K | Frazier Life Sciences Acquisition Corp. II Reports Balance Sheet and Initial Public Offering Details as of October 15, 2026 | ||
SCHEDULE 13G | RA CAPITAL MANAGEMENT, L.P. (Filed by) | ||
SCHEDULE 13D | Frazier Life Sciences Holdings II LLC (Filed by) | ||
SCHEDULE 13G | BIOTECHNOLOGY VALUE FUND L P (Filed by) | ||
SCHEDULE 13G | Deep Track Capital, LP (Filed by) | ||
SCHEDULE 13G | Coastlands Capital LP (Filed by) | ||
4 | Cha Albert (Reporting) | ||
8-K | Frazier Life Sciences Acquisition Corp. II Announces Closing of Initial Public Offering and Private Placement | ||
424B4 | Form 424B4 | ||
EFFECT | Form EFFECT | ||
3 | Li Kevin (Reporting) |
